Table 1 Association of DNAJC5 expression levels with clinicopathologic characteristics in LUAD
Clinicopathologic characteristics | n | DNAJC5 expression | p-value | |
|---|---|---|---|---|
High (%) | Low (%) | |||
Gender | 210 | |||
Male | 87 (41.4%) | 14 (6.7%) | 0.702 | |
Female | 91 (43.3%) | 17 (8.1%) | ||
Age (years) | 210 | |||
< 60 | 88 (42.1%) | 17 (8.1%) | 0.579 | |
≥ 60 | 90 (43.1%) | 14 (6.7%) | ||
Tumor size (cm) | 210 | |||
≤ 3 | 114 (54.5%) | 18 (8.6%) | 0.524 | |
> 3 | 64 (30.6%) | 13 (6.2%) | ||
Differentiation | 210 | |||
Well | 53 (25.2%) | 14 (6.7%) | 0.007 | |
Moderate | 71 (33.8%) | 11(5.2%) | ||
Poor | 54 (25.7%) | 6 (2.9%) | ||
Lymph node metastasis | 210 | |||
Yes | 61 (29.2%) | 9 (4.3%) | 0.569 | |
No | 117 (56.0%) | 22 (10.5%) | ||
TNM stage | 210 | |||
StageI-II | 163 (78%) | 26 (12.4%) | 0.188 | |
StageIII-IV | 15 (7.2%) | 5 (2.4%) | ||
Metastasis | 210 | |||
Yes | 55 (26.3%) | 3 (1.4%) | 0.015 | |
No | 123 (58.9%) | 28 (13.4%) | ||
Smoke | 210 | |||
Yes | 69 (33.3%) | 12 (5.8%) | 0.958 | |
No | 107 (51.7%) | 19 (9.2%) |
